Table 1.
Patient characteristics.
| Characteristic | Non‐diabetic patients | Diabetic patients | P‐value |
|---|---|---|---|
| Number of individuals | 1275 | 246 | |
| Age (years) | 65 (64–65) | 65 (65–66) | |
| Body mass index (kg m2) | 28·4 (28·2–28·7) | 30·7 (30·1–31·2) | |
| Sex [female, n (%)] | 677 | 86 | |
| White cell count (cells 109 l–1) | 7·3 (7·2–7·4) | 8·0 (7·7–8·4) | <0·0005 |
| Lymphocyte count (cells 109 l–1) | 28·0 (27·4–28·5) | 26·7 (25·5–27·9) | <0·05 |
| Neutrophil count (cells 109 l–1) | 61·1 (60·6–61·7) | 63·1 (61·7–64·6) | <0·005 |
| Eosinophils count (cells 109 l–1) | 2·6 (2·5–2·8) | 3·0 (2·7–3·3) | <0·05 |
| Monocyte count (cells 109 l–1) | 8·1 (7·9–8·3) | 7·7 (7·5–8·0) | 0·4 |
| Platelets (cells 109 l–1) | 263 (252–274) | 258 (254–262) | 0·16 |
Descriptive leucocyte data for healthy patients and patients with type 2 diabetes. Data were controlled for gender and age as a continuous covariate, patients with metastatic disease were excluded. All values mean proportion (95% confidence interval) or n (%).